Rights and permissions
About this article
Cite this article
Catumaxomab delays QOL deterioration in malignant ascites. Pharmacoecon. Outcomes News 659, 10 (2012). https://doi.org/10.2165/00151234-201206590-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206590-00028